FDA Drug Shortage Database
Atropine (Atropen) shortage
The FDA Drug Shortage Database lists 6 of 19 atropine presentations as limited or unavailable (updated October 5, 2026); the first entry was posted on January 1, 2012. 11 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 0.1mg/1ml injection | 0 | 1 | 0 |
| 0.25mg/5ml injection | 0 | 1 | 0 |
| 0.4mg/1ml injection | 0 | 1 | 0 |
| 0.5mg/5ml injection | 0 | 0 | 1 |
| 1mg/10ml injection | 1 | 1 | 1 |
| 1mg/1ml injection | 2 | 3 | 0 |
| 4mg/1ml injection | 2 | 4 | 0 |
| 05mg/1ml injection | 1 | 0 | 0 |
Which presentations are listed?
Limited or unavailable now (6)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) | Accord Healthcare Inc. | Current posted January 1, 2020, updated October 3, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) | Accord Healthcare Inc. | Current posted January 1, 2020, updated October 3, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) | Accord Healthcare Inc. | Current posted January 1, 2012, updated September 1, 2026 | Unavailable; Requirements related to complying with good manufacturing practices |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) | Accord Healthcare Inc. | Current posted January 1, 2012, updated September 1, 2026 | Unavailable; Requirements related to complying with good manufacturing practices |
| Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) | Accord Healthcare Inc. | Current posted January 1, 2012, updated September 1, 2026 | Unavailable; Requirements related to complying with good manufacturing practices |
| Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10) | Hospira, Inc., a Pfizer Company | Current posted January 1, 2012, updated August 24, 2026 | Unavailable; Other |
Listed now, available (11)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) | Amphastar Pharmaceuticals, Inc. | Current posted January 1, 2020, updated October 5, 2026 | Available |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) | American Regent, Inc. | Current posted January 1, 2012, updated October 1, 2026 | Available |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) | Fresenius Kabi USA, LLC | Current posted January 1, 2012, updated September 1, 2026 | Available |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10) | Somerset Therapeutics, LLC | Current posted January 1, 2012, updated September 11, 2026 | Available |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25) | Somerset Therapeutics, LLC | Current posted January 1, 2012, updated September 11, 2026 | Available |
| Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) | Accord Healthcare Inc. | Current posted January 1, 2020, updated October 3, 2026 | Available |
| Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) | Hospira, Inc., a Pfizer Company | Current posted January 1, 2012, updated September 22, 2026 | Available |
| Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) | Hikma Pharmaceuticals USA, Inc. | Current posted December 20, 2023, updated September 18, 2026 | Available |
| Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) | American Regent, Inc. | Current posted January 1, 2012, updated October 1, 2026 | Available |
| Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25) | Somerset Therapeutics, LLC | Current posted January 1, 2012, updated September 11, 2026 | Available |
| Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) | Medefil, Inc. | Current posted January 1, 2012, updated September 15, 2026 | Available |
Resolved or discontinued (2)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)" | Hospira, Inc., a Pfizer Company | To Be Discontinued posted November 7, 2025, updated November 7, 2025 | not given |
| Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)" | Hospira, Inc., a Pfizer Company | To Be Discontinued posted November 7, 2025, updated November 7, 2025 | not given |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage